Forxiga HF General Drug Use-Results Study

Trial Identifier: D1699C00017
Sponsor: AstraZeneca
NCTID:: NCT04865406
Start Date: May 2021
Primary Completion Date: December 2024
Study Completion Date: December 2024
Condition: Congestive Heart Failure

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Japan Akita, Japan
Japan Aomori, Japan
Japan Fukui, Japan
Japan Fukushima, Japan
Japan Kagawa, Japan
Japan Kochi, Japan
Japan Nagasaki, Japan
Japan Shiga, Japan
Japan Toyama, Japan
Japan Yamagata, Japan